SCHEMBL20111327

SCHEMBL20111327

CCOc1ccc2c(c1F)-c1c-2cc(C2CCCCO2)c(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
APOBEC3G Q9HC16 2/20 0.33
PTGDR2 Q9Y5Y4 5/20 0.33
MAPT P10636 4/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SCN9A Q15858 2/20 0.32
CREBBP Q92793 1/20 0.32
HPGD P15428 2/20 0.32
NPSR1 Q6W5P4 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111482 0.84 PRKAG1 (0.39) ALDH1A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL20102450 0.83 PTGDR2 (0.37) ALDH1A1APOBEC3GPTGDR2MAPTHPGD
SCHEMBL20102455 0.82 PTGDR2 (0.39) ALDH1A1APOBEC3GPTGDR2MAPTKMT2A
SCHEMBL20111583 0.82 PTGDR2 (0.39) ALDH1A1APOBEC3GPTGDR2MAPTKMT2A
SCHEMBL20102451 0.81 ALOX5AP (0.36) PTGDR2KDM1A
SCHEMBL20102453 0.80 KDM1A (0.36) ALDH1A1APOBEC3GPTGDR2MAPTHPGD
SCHEMBL20102445 0.79
SCHEMBL20111246 0.76 FPR2 (0.32) L3MBTL1KDM1A
SCHEMBL20111610 0.76 KDM1A (0.33) ALDH1A1APOBEC3GPTGDR2MAPTKMT2A
SCHEMBL20117597 0.76 ALDH1A1 (0.34) ALDH1A1SCN9AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S ALDH1A1 1182/4885KDM4E 1555/4885L3MBTL1 177/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S ALDH1A1 1182/4885KDM4E 1555/4885L3MBTL1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.